Antimicrobial lethality is promoted by reactive oxygen species (ROS) such as superoxide, peroxide, and hydroxyl radical. Pretreatment with subinhibitory concentrations of plumbagin or paraquat, metabolic generators of superoxide, paradoxically reduced killing for oxolinic acid, kanamycin, and ampicillin. These pretreatments also reduced an oxolinic acid-mediated ROS surge. Defects in SoxS-MarA or AcrB eliminated plumbagin-and paraquat-mediated MIC increases but maintained protection from killing. Thus, superoxide has both protective and detrimental roles in response to antimicrobial stress.
Antimicrobial resistance has become a grave challenge for human healthcare. One counter-measure is to increase our ability to kill pathogens, since rapid, extensive killing should help restrict the emergence of resistance (1) (2) (3) . A general vulnerability of bacteria to antimicrobial therapy may lie in their response to oxidative stress: many different antimicrobial classes act, at least in part, through the generation of reactive oxygen species (ROS (4-6)). Thus, promoting a surge in ROS should enhance antimicrobial lethality. In particular, increased superoxide could lead to increased peroxide and subsequently increased hydroxyl radical and cell death (4, 5) .
Paradoxically, superoxide may also have a protective role, as suggested by the observation that sub-inhibitory concentrations of plumbagin, a metabolic generator of superoxide (7), reduces the killing of Escherichia coli by bleomycin, a lethal DNA-damaging agent (8) . However, bleomycinbased studies are complex, because superoxide is also involved in bleomycin activation (9) .
Thus, it is uncertain whether plumbagin can protect bacteria from many different lethal antimicrobials, as required for superoxide to play a central role in the live-or-die decision made by bacteria when challenged with lethal stressors (10, 11) .
In the present work we treated strains of Escherichia coli K-12 (listed in Table 1 ) with subinhibitory concentrations of plumbagin or paraquat, another metabolic generator of superoxide (12, 13) , to assess the effect of moderate superoxide levels on the lethal activity of several antimicrobials. E. coli was grown aerobically at 37°C in LB liquid medium and on LB agar (14) . All antimicrobials, plumbagin, and paraquat were obtained from Sigma-Aldrich (St.
Louis, MO). Antimicrobial susceptibility (MIC) was measured by broth dilution according to the Clinical and Laboratory Standards Institute (CLSI) protocol (15) . Lethal action was measured by growing cultures to mid-log phase, treating with antimicrobial, and then plating on drug-free agar for determining percent survival relative to aliquots taken immediately before antimicrobial addition. Intracellular ROS levels were measured by flow cytometry (16) using At subinhibitory concentrations (1/4 MIC), plumbagin and paraquat showed no effect on exponential growth rate, although they did cause a 30-60 min delay in entering exponential growth phase following dilution of stationary-phase cultures (Fig. S1 ). With wild-type cells, plumbagin and paraquat reduced bacteriostatic activity of antimicrobials, as shown by increased MIC for oxolinic acid, ampicillin, and kanamycin (4-, 2-, and 2-fold, respectively (Table 2) ). When overnight cultures were diluted 100-fold with fresh medium containing plumbagin at 1/4 MIC, grown to exponential phase, and then treated with antimicrobials, lethal activity for oxolinic acid, kanamycin, and ampicillin decreased when measured at a fixed concentration of drug for various times (Fig. 1A , C, E) or at various drug concentrations for a fixed time (Fig. 1B, D, F) . Paraquat also decreased the lethal action of these antimicrobials (Fig. 2) , but it did not affect killing by UV or heat (Fig. S2) . Nor did it convert chloramphenicol into a lethal agent (Fig. S2) . Thus, the two metabolic generators of superoxide protect E. coli from the lethal action of several different antimicrobial classes. Since antimicrobial concentrations were normalized to MIC, protection from killing was not due simply to the increase in MIC shifting concentration-kill curves.
We next asked whether superoxide-mediated protection correlated with ROS levels associated with antimicrobial treatment. Wild-type cells were grown to mid-log phase in the presence or absence of 1/4 MIC plumbagin or paraquat before they were treated with oxolinic acid. At 90 min after oxolinic acid addition, aliquots from both quinolone-treated and untreated samples were pulse-labeled for 60 min with Carboxy-H2DCFDA, a fluorescent probe that reacts with all three ROS (superoxide, peroxide, and hydroxyl radical). Then aliquots were analyzed by flow cytometry. Treatment with oxolinic acid markedly increased the fluorescent signal ( Since superoxide induces the SoxS and MarA transcription factors that activate protective repair pathways and efflux pumps (17-19), we next asked whether paraquat-mediated protection from antimicrobials is mediated by these two superoxide-activated regulators. A soxS-marA double deletion eliminated paraquat-and plumbagin-associated MIC increases seen with wildtype cells (Table 2) , implicating both gene products in bacteriostatic effects (single deletions showed partial effects (data not shown)). However, the double deletion failed to eliminate paraquat-mediated protection from killing (Fig. 4A, C, E) . Thus, superoxide-mediated protection from killing extends beyond up-regulation of efflux pumps.
Since the AcrAB-TolC efflux system is the major pump under Sox-MarA control, we also examined an acrB-deficient mutant for paraquat-mediated protection from killing by oxolinic acid, kanamycin, and ampicillin. The acrB mutation reduced MIC by 8-, 3-, and 2-fold for oxolinic acid, ampicillin, and kanamycin, respectively (Table 2 ). Paraquat and plumbagin failed to increase MIC in the acrB mutant ( Table 2 ), indicating that the MIC increase induced by these agents in wildtype cells is due to increased AcrAB-TolC pump activity. But the acrB mutation allowed paraquatmediated protection from killing to occur (Fig. 4B, D, F) . Thus, AcrA-TolC-mediated efflux is not required for superoxide-mediated protection from antimicrobial killing.
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During the course of the work, pretreatment with paraquat or plumbagin was reported to increase the level of persister cells and confer tolerance to killing by fluoroquinolones, but not by ampicillin or kanamycin (20) . That work used a short paraquat/plumbagin pretreatment time (30 min), which might have prevented them from observing protective effect with ampicillin and kanamycin. Since plumbagin increased MIC by 4-fold for quinolones but no more than 2-fold for ampicillin and kanamycin (Table 2) , the greater effect on quinolone MIC could shift concentrationkill curves more for quinolones and appear to decrease killing only for quinolones in that work (20) . When we used a range of drug concentrations for concentration-kill curves and normalized concentrations to MIC for killing kinetics, pretreatment with subinhibitory concentrations of plumbagin or paraquat for 120-150 min reduced bacterial killing by all three drug classes tested (Figs 1 and 2) . Our results are consistent with persister cells usually being tolerant to a variety of stressors over a broad range of drug concentrations and exposure times (21).
The results described above establish that a moderate increase in superoxide can protect from a variety of lethal antimicrobials, possibly by activating ROS defense systems that help suppress the ROS surge triggered by subsequent antimicrobial treatment (Fig. 3) . However, once superoxide exceeds a critical level, it becomes highly lethal (Fig. S3) . The protective effect of moderate levels of superoxide extends beyond MIC changes mediated by SoxS-MarA and AcrAB-TolC, since protection from killing was also observed with soxS-marA and acrB mutant cells that showed no plumbagin-or paraquat-mediated MIC change. Moreover, an efflux inhibitor, verapamil, decreased MIC of AZI-219 (an experimental antituberculosis agent) but showed no increase in killing if drug concentrations were normalized to MIC (22) . We conclude that superoxide-induced SoxS-MarA-mediated up-regulation of drug efflux is not the only protective superoxide action, as recently suggested (20) . Since subinhibitory concentrations of plumbagin and paraquat affect the expression of hundreds of genes (23, 24) , some of these gene The protective effect of superoxide generators (Figs. 1-2 ) and a sodA-sodB double mutant (5) to lethal stress, combined with the destructive effect of ROS described previously ( Fig. S3 and   (4, 5) ), lead us to speculate that ROS have two opposing functions during lethal stress. A large surge in ROS assures death (4, 6, 11, 25) while a moderate increase in superoxide triggers protective pathways to lethal stress ( Figs 1-4 and (20)). Whether ROS stimulate or mitigate stress-mediated cell death depends on stress type and severity (10) , which makes the choice of stressor and experimental conditions crucial for determining whether ROS are detrimental, protective, or of no effect (10, 16, 20, 26) . These observations indicate that the ROS contribution to antimicrobial lethality may be more complex than originally envisioned (4). These complexities indicate that challenges to ROS having an important role in antimicrobial lethality (27-29) require examination of a broad set of stressor types and experimental conditions. 
